To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years

Conditions:   Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis Intervention:   Biological: DTaP-IPV combination vaccine Sponsor:   Boryung Biopharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials